日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Emergence of a novel genotype of extensively drug-resistant Shigella sonnei carrying blaDHA-1 in diverse patient populations, Los Angeles, 2024-2025

2024-2025年,洛杉矶不同患者群体中出现携带blaDHA-1基因的新型广泛耐药性宋内氏志贺菌基因型

Gonzalez-Ferrer, Shekina; Shaw, Bennett; Fung, Lilian; Landovitz, Raphael J; Uslan, Daniel Z; Yang, Shangxin

Preferences for HIV prevention conditional cash transfers among Black/African American and Latinx cisgender MSM in Los Angeles

洛杉矶黑人/非裔美国人和拉丁裔顺性别男男性行为者对艾滋病预防条件现金转移支付的偏好

Moucheraud, Corrina; Trujillo, Dillon; Wagner, Zachary; Garland, Wendy; Smith, Terry; Hoffman, Risa M; Landovitz, Raphael J

Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial Sexually Transmitted Infections: A Secondary Analysis of HPTN 083

卡博特韦在细菌性传播感染中仍保持保护效力:HPTN 083 的二次分析

Clement, Meredith E; Hanscom, Brett; Haines, Daniel; Bazan, Jose A; Chotirosniramit, Nuntisa; Kofron, Ryan; Mannheimer, Sharon; Mayer, Kenneth H; Torres Silva, Mayara Secco; Soto-Torres, Lydia; Rinehart, Alex R; Rooney, James F; Jennings, Andrea; Gomez-Feliciano, Kailazarid; McCauley, Marybeth; Grinsztejn, Beatriz; Landovitz, Raphael J

Estimation of Prevention-Effective CAB-LA Concentrations Among Men Who Have Sex With Men (MSM) and Transgender Women (TGW) in HPTN 083

HPTN 083 中男男性行为者 (MSM) 和跨性别女性 (TGW) 预防有效 CAB-LA 浓度的估计

Hanscom, Brett; Marzinke, Mark A; Li, Xinnong; Donnell, Deborah; Bies, Robert; Hendrix, Craig W; Wang, Zhe; Acuipil, Carolina; Rinehart, Alex; Collins, Jon W; Rooney, James F; Soto Torres, Lydia; Richardson, Paul; Chariyalerstsak, Suwat; Valdez Ramalho Madruga, Jose; Hurt, Christopher B; Magnus, Manya; Frank, Ian; McCauley, Marybeth; Grinsztejn, Beatriz; Landovitz, Raphael J

Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084

评估长效卡博特韦在东非和南部非洲孕妇中的安全性和药代动力学:HPTN 084 的二次分析

Delany-Moretlwe, Sinead; Hanscom, Brett; Guo, Xu; Nkabiito, Clemensia; Mandima, Patricia; Nahirya, Patricia Ntege; Mpendo, Juliet; Bhondai-Mhuri, Muchaneta; Mgodi, Nyaradzo; Berhanu, Rebecca; Farrior, Jennifer; Piwowar-Manning, Estelle; Ford, Susan L; Hendrix, Craig W; Rinehart, Alex R; Rooney, James F; Adeyeye, Adeola; Landovitz, Raphael J; Cohen, Myron S; Hosseinipour, Mina C; Marzinke, Mark A

Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection

广谱中和抗体VRC01LS和VRC07-523LS对慢性HIV-1感染的病毒学影响

Happe, Myra; Lynch, Rebecca M; Fichtenbaum, Carl J; Heath, Sonya L; Koletar, Susan L; Landovitz, Raphael J; Presti, Rachel M; Santana-Bagur, Jorge L; Tressler, Randall L; Holman, LaSonji A; Novik, Laura; Roa, Jhoanna C; Rothwell, Ro Shauna; Strom, Larisa; Wang, Jing; Hu, Zonghui; Conan-Cibotti, Michelle; Bhatnagar, Anjali M; Dwyer, Bridget; Ko, Sung Hee; Belinky, Frida; Namboodiri, Aryan M; Pandey, Janardan P; Carroll, Robin; Basappa, Manjula; Serebryannyy, Leonid; Narpala, Sandeep R; Lin, Bob C; McDermott, Adrian B; Boritz, Eli A; Capparelli, Edmund V; Coates, Emily E; Koup, Richard A; Ledgerwood, Julie E; Mascola, John R; Chen, Grace L; Tebas, Pablo

Bone Changes With Long-Acting Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention in Cisgender Men and Transgender Women: HPTN 083

长效卡博特韦或富马酸替诺福韦二吡呋酯/恩曲他滨用于顺性别男性和跨性别女性HIV预防的骨骼变化:HPTN 083

Brown, Todd T; Arao, Robert F; Warsi, Maryam; Phanuphak, Nittaya; Vasconcelos, Ricardo; Oyedele, Temitope; Sullivan, Philip A; Hanscom, Brett; Rooney, James F; Rinehart, Alex R; McCauley, Marybeth; Grinsztejn, Beatriz; Landovitz, Raphael J

Cabotegravir pharmacokinetics in Asians with and without HIV

卡博特韦在亚洲人群(包括HIV感染者和未感染者)中的药代动力学

Han, Kelong; Abulfathi, Ahmed A; Mehta, Rashmi S; Nand, Romina A; Marzinke, Mark A; Landovitz, Raphael J; D'Amico, Ronald D; Rinehart, Alex R; Spreen, William R; Ford, Susan L

Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial

在美国,一项首次人体试验(HVTN 136/HPTN 092)研究了抗HIV-1单克隆抗体PGT121.414.LS单独使用以及与VRC07-523LS联合使用时,在美国未感染HIV的成年人中的安全性、耐受性、药代动力学和中和活性。该研究为一项开放标签、随机对照的I期临床试验。

Edupuganti, Srilatha; Hurt, Christopher B; Stephenson, Kathryn E; Huang, Yunda; Paez, Carmen A; Yu, Chenchen; Yen, Catherine; Hanscom, Brett; He, Zonglin; Miner, Maurine D; Gamble, Theresa; Heptinstall, Jack; Seaton, Kelly E; Domin, Elizabeth; Lin, Bob C; McKee, Krisha; Doria-Rose, Nicole; Regenold, Stephanie; Spiegel, Hans; Anderson, Maija; McClosky, Nadia; Zhang, Lily; Piwowar-Manning, Estelle; Ackerman, Margaret E; Pensiero, Michael; Dye, Bonnie J; Landovitz, Raphael J; Mayer, Kenneth; Siegel, Marc; Sobieszczyk, Magdalena; Walsh, Stephen R; Gama, Lucio; Barouch, Dan H; Montefiori, David C; Tomaras, Georgia D

Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price

美国男男性行为者每日口服HIV暴露前预防药物:以仿制药价格节省成本

Amick, Alyssa K; Eskibozkurt, G Ege; Hosek, Sybil G; Flanagan, Clare F; Landovitz, Raphael J; Jin, Elena Y; Wilson, Craig M; Freedberg, Kenneth A; Weinstein, Milton C; Kazemian, Pooyan; Paltiel, A David; Ciaranello, Andrea L; Neilan, Anne M